The Effect of Addition of Metformin In Obese Non- Diabetic Patients With Heart Failure With Preserved Ejection Fraction

Category Systematic review
Registry of TrialsClinicalTrials.gov
Year 2023
Diabetes mellitus people have a higher incidence of cardiovascular disease, and the results of cardiovascular events are worse. Heart failure and diabetes both have a worse prognosis, with a 1.5-2 times increased risk of death. Data from the literature have shown that MET lowers mortality by 14-35% in this patient population, which represents one-third of all HF patients with no increases in lactic acidosis incidence.
Epistemonikos ID: 72153e0a337f58d7a6dccc9d6841dec1f47f498c
First added on: Feb 19, 2024